Cancers arise from successive rounds of mutation and selection, generating clonal populations that vary in size, mutational content and drug responsiveness. Ascertaining the clonal composition of a tumor is therefore important both for prognosis and therapy. Mutation counts and frequencies resulting from next-generation sequencing (NGS) potentially reflect a tumor’s clonal composition; however, deconvolving NGS data to infer a tumor’s clonal structure presents a major challenge. We propose a generative model for NGS data derived from multiple subsections of a single tumor, and we describe an expectation-maximization procedure for estimating the clonal genotypes and relative frequencies using this model. We demonstrate, via simulation, the v...
Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogen...
Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogen...
The sensitivity of massively-parallel sequencing has confirmed that most cancers are oligoclonal, wi...
<div><p>Cancers arise from successive rounds of mutation and selection, generating clonal population...
Clonal deconvolution of mutational landscapes is crucial to understand the evolutionary dynamics of ...
Traditional classifications and treatment of human cancers have operated with limitations surroundin...
Intra-tumor heterogeneity presents itself through the evolution of subclones during cancer progressi...
Intra-tumor heterogeneity concerns the existence of genetically different subclones within the same ...
Knowledge about the clonal evolution of a tumor can help to interpret the function of its genetic al...
© 2020, The Author(s). Knowledge about the clonal evolution of a tumor can help to interpret the fun...
Intra-tumor heterogeneity concerns the existence of genetically different subclones within the same ...
Intra-tumor heterogeneity concerns the existence of genetically different subclones within the same ...
Knowledge about the clonal evolution of each tumor can inform driver-alteration discovery by pointin...
The extensive genetic heterogeneity of cancers can greatly affect therapy success due to the existen...
SummaryThe extensive genetic heterogeneity of cancers can greatly affect therapy success due to the ...
Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogen...
Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogen...
The sensitivity of massively-parallel sequencing has confirmed that most cancers are oligoclonal, wi...
<div><p>Cancers arise from successive rounds of mutation and selection, generating clonal population...
Clonal deconvolution of mutational landscapes is crucial to understand the evolutionary dynamics of ...
Traditional classifications and treatment of human cancers have operated with limitations surroundin...
Intra-tumor heterogeneity presents itself through the evolution of subclones during cancer progressi...
Intra-tumor heterogeneity concerns the existence of genetically different subclones within the same ...
Knowledge about the clonal evolution of a tumor can help to interpret the function of its genetic al...
© 2020, The Author(s). Knowledge about the clonal evolution of a tumor can help to interpret the fun...
Intra-tumor heterogeneity concerns the existence of genetically different subclones within the same ...
Intra-tumor heterogeneity concerns the existence of genetically different subclones within the same ...
Knowledge about the clonal evolution of each tumor can inform driver-alteration discovery by pointin...
The extensive genetic heterogeneity of cancers can greatly affect therapy success due to the existen...
SummaryThe extensive genetic heterogeneity of cancers can greatly affect therapy success due to the ...
Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogen...
Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogen...
The sensitivity of massively-parallel sequencing has confirmed that most cancers are oligoclonal, wi...